Keyphrases
Leprosy
100%
Tuberculosis
100%
D-cycloserine
58%
Bedaquiline
58%
Dapsone
58%
Rifamycin
58%
Ethambutol
58%
Pyrazinamide
58%
Drug Interactions
58%
Delamanid
50%
Tuberculosis Treatment
50%
Treatment Regimen
41%
Liposomal Amphotericin B
33%
Staphylococcus Aureus Bacteremia
33%
Treatment Considerations
33%
XDR-tuberculosis
33%
Tuberculosis Drugs
33%
Gatifloxacin
33%
Kanamycin
33%
Extensively Drug-resistant Tuberculosis
33%
Capreomycin
33%
Mycobacterium Leprae
33%
Ginsenoside
33%
Adverse Effect Profile
33%
Antifungal Prophylaxis
33%
Multidrug Resistance
33%
Positive Blood Culture
33%
Drug Use
33%
Extended-spectrum β-lactamase
33%
Tolerability
33%
Methicillin-resistant Staphylococcus Aureus
33%
Infection Treatment
33%
Diagnostic Considerations
33%
Multidrug-resistant Tuberculosis (MDR-TB)
33%
Urinary Tract Infection
33%
Moxifloxacin
33%
Mycobacterium Tuberculosis (M. tb)
33%
Side Effect Profile
33%
Infection Diagnosis
33%
Pharmacokinetic Drug Interactions
33%
High Dose
33%
Older Adults
33%
Panax Notoginseng
33%
Levofloxacin
33%
Panax Ginseng
33%
Pharmacokinetic Study
27%
Terizidone
25%
Aminoglycosides
25%
5-aminosalicylic Acid (5-ASA)
25%
Clofazimine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cycloserine
66%
Bedaquiline
66%
Dapsone
66%
Ethambutol
66%
Pyrazinamide
66%
Rifamycin
66%
Isoniazid
66%
Delamanid
50%
Adverse Event
50%
Pharmacokinetics
50%
Extended Spectrum Beta Lactamase
33%
Tuberculosis
33%
Leprosy
33%
Terizidone
33%
Aminosalicylic Acid
33%
Thioacetazone
33%
Urinary Tract Infection
33%
Capreomycin
33%
Gatifloxacin
33%
Extensively Drug-Resistant Tuberculosis
33%
Multi-Drug-Resistant Tuberculosis
33%
Clofazimine
33%
Kanamycin
33%
Aminoglycoside
33%
Carbapenem Derivative
33%
Polypeptide
33%
Linezolid
33%
Quinolone Derivative
33%
Macrolide
33%
Mycobacterium Tuberculosis
33%
Multiple Drug Resistance
33%
Tolerability
33%
Drug Interaction
33%
Side Effect
33%
Moxifloxacin
33%
Methicillin Resistant Staphylococcus Aureus Infection
33%
Amphotericin B
33%
Ginseng
33%
Levofloxacin
33%
Antifungal Agent
33%
Antibiotic Agent
24%
Daptomycin
20%
Vancomycin
20%
Latent Tuberculosis
16%
Systemic Mycosis
16%
Adverse Drug Reaction
16%
Hematologic Malignancy
16%
Spondylitis
13%
Warfarin
8%
CYP3A
8%